MOTIVATION TO STUDY THE EFFECT OF PLATELET-RICH PLASMA (PRP) ON POST-CHEMOTHERAPY ALOPECIA (APC) AND POST-ENDOCRINE THERAPY ALOPECIA (APE). Leore LAVIN MS, Alex PAN MD, Anthony ROSSI MD, Antoine TURZI.
MOTIVATION TO STUDY THE EFFECT OF PRP ON CHEMOTHERAPY-INDUCED ALOPECIA (CIA) AND ENDOCRINE THERAPY-INDUCED ALOPECIA (EIA). Leore LAVIN MS, Alex PAN MD, Anthony ROSSI MD, Antoine TURZI, CEO Regen Lab. THE FINDING: ADDITIONAL TREATMENT OPTIONS ARE NEEDED FOR PATIENTS SUFFERING FROM ALOPECIA RESULTING FROM ENDOCRINE THERAPY.
CORRECTION OF AGE-RELATED CHANGES WITH AUTOLOGOUS THROMBIN-ACTIVATED PRP AND HYALURONIC ACID IN COMBINATION WITH RF-MICRONEEDLING EQUIPMENT. Inna SHARYPOVA, MD, PhD. Andrey ALENICHEV, MD, PhD.
LM SURVEY ON ANTI-AGING THERAPEUTIC PROCEDURES CORRECTION OF AGE RELATED CHANGES WITH AUTOLOGOUS THROMBINE AND HYALURONIC ACID ACTIVATED PLASMA IN COMBINATION WITH MICRONEEDLING RF EQUIPMENT Inna SHARYPOVA, M.D., Ph.D. Andrey ALENICHEV, M.D., Ph.D. Dermatologists, Kristel Medical, Milan THE RELEVANCE OF [...] INFORMATION
PLATELET-RICH PLASMA AS A SAFE AND EFFECTIVE AUTOLOGOUS TREATMENT FOR CHRONIC WOUND HEALING. Solange VISCHER, Antoine TURZI.
PLATE-RICH PLASMA AS A SAFE AND EFFECTIVE AUTOLOGOUS TREATMENT FOR THE CICATRIZATION OF CHRONIC WOUND Solange VISCHER, Senior Scientific Advisor, Regen Lab SA. Antoine TURZI CEO, Regen Lab SA. Abstract Platelet-rich plasma (PRP) is an autologous biologic drug prepared from a patient's own blood and used as a treatment for the treatment of chronic [...].
OVERVIEW OF REGENLAB'S PATENTED TECHNOLOGIES. Andreas PIGNI. Legal Affairs, RegenLab SA.
OVERVIEW OF REGENLAB'S PATENTED TECHNOLOGIES Andreas PIGNI Legal Affairs, RegenLab SA INTRODUCTION RegenLab SA has established itself as a pioneer and leader in regenerative medicine, known for its innovative technologies that synergistically use platelet-rich plasma (PRP) in combination with various bioactive/therapeutic agents, thus providing solutions to [...].
REGENPRP®, A STANDARDIZED AUTOLOGOUS PLATELET CONCENTRATE. 10 YEARS OF RESEARCH AND PRACTICE. Pr Barbara Hersant Editor-in-Chief, L&M
Platelet Rich Plasma (PRP) has emerged as an innovative therapeutic modality in the
various medical fields, offering promising prospects for wound healing, the
facial rejuvenation and even genital rejuvenation.
Our clinical research is resolutely committed to studying these applications, seeking to determine
the efficacy and safety of RegenPRP® (standardized PRP prepared with RegenLab SA technology),
Switzerland) in these varied clinical contexts.
This technology makes it possible to obtain liquid RegenPRP, in the form of autologous fibrin sealant or fibrin glue.
combined with hyaluronic acid (Cellular Matrix® technology) to meet different needs
therapeutics.
-
In the field of wound healing, RegenPRP is attracting growing interest due to the following factors
its regenerative properties and its potential to accelerate the healing process. Our
research aims to deepen our understanding of how RegenPRP can optimize the
healing of post-operative and traumatic wounds, improving clinical outcomes for patients and their families.
patients.
-
Facial rejuvenation is one area where RegenPRP has become an increasingly popular option.
increasingly popular. By harnessing the cell regeneration capabilities of RegenPRP, our study
examines how this therapy can be used safely and effectively to alleviate the signs of aging.
of skin ageing, offering a non-surgical alternative to traditional
facial rejuvenation.
-
In a revolutionary way, our research also explores the possibilities of rejuvenation.
using RegenPRP. This innovative approach aims to restore function and appearance
of the genitalia, offering a new means of treatment for patients suffering from
sexual dysfunction and aesthetic problems in this region.
It should be noted that all our studies are conducted in compliance with the most stringent standards in the field.
ethics and regulations. Approved by the French medical agency and supervised by a
independent ethics committee, our prospective studies guarantee the scientific rigor and safety of our products.
participants.
Our clinical research on RegenPRP is opening up exciting new perspectives in the fields of
wound healing, facial rejuvenation and genital rejuvenation through the combination of a
rigorous scientific approach with a commitment to medical innovation. We aim to improve
clinical results and patients' quality of life thanks to this promising therapy.
Key words: RegenPRP®, Cellular Matrix®, combination of RegenPRP® and hyaluronic acid, surgery
plastic, skin grafting, vulvovaginal atrophy, keloid scars, mesenchymal stromal cells.
